BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 2, 2009
View Archived Issues
Ginseng extract CVT-E002 shows promise in mouse model of asthma
Read More
Dexmedetomidine shows favorable pharmacokinetics for long-term sedation in renal failure patients
Read More
Recent Roche patent describes new benzimidazole derivatives for lipoprotein disorders
Read More
Botulinum toxin effective without anticholinergics in neurogenic detrusor hyperactivity
Read More
Novel histone deacetylase inhibitors presented by Karus Therapeutics
Read More
AstraZeneca discloses new series of Janus kinase inhibitors for cancer treatment
Read More
Dopamine D3 receptor antagonists may have potential for treating premature ejaculation
Read More
Ligand and GlaxoSmithKline collaboration identifies new lead compound
Read More
Merck KGaA and Yissum sign agreement to develop semiconductor nanoparticles
Read More
Roche claims pyridoneamide derivatives as focal adhesion kinase inhibitors
Read More
Halozyme commences PEGPH-20 dosing in patients with refractory solid tumors
Read More
Wyeth submits BLA to FDA for its 13-valent pneumococcal vaccine
Read More
FDA Advisory Committee recommends accelerated approval for Avastin
Read More
GSK's Synflorix pneumococcal vaccine receives European authorization
Read More
PF-04217903 pharmacokinetics investigated in phase I study
Read More
Phase I data on AVE-8062 in advanced solid tumor patients presented
Read More
Tadalafil lowers the ApoB/ApoA-1 ratio in healthy men
Read More
Pharming to submit MAA to EMEA for Rhucin in HAE in September 2009
Read More
GSK submits final data to FDA from phase III HPV-008 clinical study of Cervarix
Read More
QuatRx completes enrollment in second phase III clinical trial of Ophena for vaginal atrophy
Read More
NeuroSearch presents update on clinical development programs
Read More
Celtic reports positive results from phase II trial of TDT-067 for onychomycosis
Read More
GSK submits lapatinib for first-line breast cancer treatment in U.S. and E.U.
Read More
DiaMedica reports top-line results from phase IIa DM-99 study in type 2 diabetes
Read More
Once-weekly exenatide offers superior glucose control to sitagliptin or pioglitazone
Read More
KAI initiates second phase II trial for KAI-1678 in neuropathic pain
Read More
